A randomized, phase II trial of AEZS-108 in chemotherapy refractory triple-negative (ER/PR/HER2-negative) LHRH-R positive metastatic breast cancer

Buchholz, Stefan and Engel, Joerg and Schally, Andrew V. and Seitz, Stephan and Ortmann, Olaf and Emons, Guenter and Mahtani, Reshma L. and Gluck, Stefan and Vogel, Charles L. and Montero, Alberto J. (2013) A randomized, phase II trial of AEZS-108 in chemotherapy refractory triple-negative (ER/PR/HER2-negative) LHRH-R positive metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): TPS11124. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Depositing User: Petra Gürster
Date Deposited: 04 Jun 2020 10:34
Last Modified: 04 Jun 2020 10:34
URI: https://pred.uni-regensburg.de/id/eprint/16658

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.